Optimi Health Corp. reveals plans for 2027 clinical trials and a shares-for-debt settlement, marking a significant step in its pharmaceutical development.
| Name | Optimi Health Corp. |
|---|---|
| CIK | 0002027329 |
| Tickers | OPTH |
| Exchanges | Nasdaq |
| Entity type | other |
| Category | — |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 000000000 |
| LEI | — |
| Fiscal year end | 0930 |
| State of incorporation | A1 British Columbia, Canada |
| Phone | 6043770403 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 0 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Optimi Health Corp. reveals plans for 2027 clinical trials and a shares-for-debt settlement, marking a significant step in its pharmaceutical development.
Optimi Health Corp. establishes Optimi Australia Pty Ltd to expand its market presence and distribution of psychedelic products in Australia.
Optimi Health Corp. announces completion of MDMA production for PTSD trials in Canada and Israel, and commercial supply in Australia.
Optimi Health Corp. announces participation in the ThinkEquity Conference, showcasing its advancements in psychedelic drug products.
48 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-18 | 6-K | FORM 6-K | 0001171843-26-007543 | 001-43304 | 261568023 | 34 | 26274 | |||
| 2026-10-26 | 6-K | FORM 6-K | 0001171843-26-006808 | 001-43304 | 261483564 | 34 | 17820 | |||
| 2026-10-20 | 6-K | FORM 6-K | 0001171843-26-006705 | 001-43304 | 261470566 | 34 | 19460 | |||
| 2026-10-07 | 6-K | FORM 6-K | 0001171843-26-006484 | 001-43304 | 261445590 | 34 | 15732 | |||
| 2026-10-05 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-113723 | 005-95729 | 261441034 | 34 | 15653 | |||
| 2026-09-29 | 6-K | FORM 6-K | 0001171843-26-006275 | 001-43304 | 261419151 | 34 | 24982 | |||
| 2026-09-23 | 6-K | FORM 6-K | 0001171843-26-006184 | 001-43304 | 261400102 | 34 | 18383 | |||
| 2026-09-22 | 6-K | FORM 6-K | 0001171843-26-006164 | 001-43304 | 261395348 | 34 | 18633 | |||
| 2026-09-16 | 6-K | FORM 6-K | 0001171843-26-006065 | 001-43304 | 261382431 | 34 | 18320 | |||
| 2026-09-10 | 6-K | FORM 6-K | 0001171843-26-005973 | 001-43304 | 261369731 | 34 | 18587 | |||
| 2026-09-08 | 6-K | FORM 6-K | 0001171843-26-005914 | 001-43304 | 261363478 | 34 | 13334 | |||
| 2026-08-27 | 424B3 | PROSPECTUS | 0001213900-26-094371 | 333-298364 | 261330067 | 33 | 1874945 | |||
| 2026-08-27 | 6-K | FORM 6-K | 0001171843-26-005754 | 001-43304 | 261324676 | 34 | 29200 | |||
| 2026-08-25 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-002760 | 333-298364 | 261317480 | 33 | 1716 | ||
| 2026-08-17 | F-1 | REGISTRATION STATEMENT | 0001213900-26-090325 | 333-298364 | 261284045 | 33 | 2827047 | 1 | 1 | |
| 2026-08-14 | 6-K | CURRENT REPORT | 0001213900-26-090286 | 001-43304 | 261283713 | 34 | 655141 | |||
| 2026-08-14 | 6-K | FORM 6-K | 0001171843-26-005554 | 001-43304 | 261283337 | 34 | 435680 | |||
| 2026-08-07 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001171843-26-005360 | 005-95729 | 261255215 | 34 | 7833 | |||
| 2026-08-07 | 6-K | FORM 6-K | 0001171843-26-005350 | 001-43304 | 261252179 | 34 | 11864 | |||
| 2026-07-28 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-082397 | 001-43304 | 261213057 | 34 | 2932818 | |||
| 2026-07-20 | 6-K | FORM 6-K | 0001171843-26-004760 | 001-43304 | 261185296 | 34 | 12289 | |||
| 2026-07-07 | S-8 | S-8 | 0001193125-26-297458 | 333-297304 | 261159400 | 33 | 232252 | 1 | 1 | |
| 2026-06-29 | 6-K | 6-K | 0001193125-26-286955 | 001-43304 | 261131527 | 34 | 28859 | |||
| 2026-06-16 | 6-K | 6-K | 0001193125-26-271863 | 001-43304 | 261092952 | 34 | 27578 | |||
| 2026-06-10 | 6-K | 6-K | 0001193125-26-265161 | 001-43304 | 261078382 | 34 | 29680 | |||
| 2026-06-08 | 6-K | 6-K | 0001193125-26-260708 | 001-43304 | 261071057 | 34 | 30184 | |||
| 2026-06-02 | 6-K | 6-K | 0001193125-26-252513 | 001-43304 | 261053631 | 34 | 26380 | |||
| 2026-06-02 | 6-K | 6-K | 0001193125-26-251855 | 001-43304 | 261052641 | 34 | 399112 | |||
| 2026-05-29 | 6-K | 6-K | 0001193125-26-247169 | 001-43304 | 261041263 | 34 | 31192 | |||
| 2026-05-27 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-066891 | 005-95729 | 261025996 | 34 | 16709 | |||
| 2026-05-26 | 6-K | 6-K | 0001193125-26-237833 | 001-43304 | 261015904 | 34 | 26753 | |||
| 2026-05-20 | 424B4 | 424B4 | 0001193125-26-231760 | 333-290086 | 261001535 | 33 | 2214299 | |||
| 2026-05-19 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-001696 | 333-290086 | 261001259 | 33 | 1716 | ||
| 2026-05-19 | CERT | 8A_CERT_OPTH_0002027329.pdf | 0001354457-26-000481 | 001-43304 | 26999747 | 34 | 178687 | |||
| 2026-05-19 | 8-A12B | 8-A12B | 0001193125-26-229777 | 001-43304 | 26996034 | 34 | 12875 | |||
| 2026-05-19 | F-1/A | F-1/A | 0001193125-26-229774 | 333-290086 | 26996023 | 33 | 2548633 | |||
| 2026-04-23 | F-1/A | F-1/A | 0001193125-26-173667 | 333-290086 | 26888632 | 33 | 2538000 | |||
| 2026-04-21 | F-1/A | F-1/A | 0001193125-26-166745 | 333-290086 | 26879433 | 33 | 210861 | 1 | 1 | |
| 2026-04-21 | F-1/A | F-1/A | 0001193125-26-165337 | 333-290086 | 26876981 | 33 | 2754637 | 1 | 1 | |
| 2026-04-16 | F-1/A | F-1/A | 0001193125-26-158975 | 333-290086 | 26867576 | 33 | 2908606 | 1 | 1 | |
| 2026-03-24 | F-1/A | F-1/A | 0001193125-26-121797 | 333-290086 | 26786244 | 33 | 2355892 | |||
| 2026-03-13 | F-1/A | F-1/A | 0001193125-26-106121 | 333-290086 | 26752493 | 33 | 2816762 | 1 | 1 | |
| 2026-02-17 | F-1/A | F-1/A | 0001193125-26-054893 | 333-290086 | 26642597 | 33 | 2313214 | |||
| 2025-09-05 | F-1 | F-1 | 0001193125-25-197327 | 333-290086 | 251297526 | 33 | 4837145 | 1 | 1 | |
| 2025-08-08 | DRS/A | filename1.htm | 0000950123-25-007260 | 377-08110 | 251195929 | 33 | 3075969 | |||
| 2025-06-16 | DRS | filename1.htm | 0000950123-25-006049 | 377-08110 | 251048133 | 33 | 3020291 | |||
| 2024-08-26 | D | xslFormDX01/primary_doc.xml | 06b | 0002027329-24-000003 | 021-522444 | 241240996 | 33 | 6160 | ||
| 2024-06-26 | D | xslFormDX01/primary_doc.xml | 06b | 0002027329-24-000002 | 021-516983 | 241073035 | 33 | 6214 |
One latest value per concept from companyfacts (5 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ffd | NetFeeAmt | NetFeeAmt | USD | 14,212.41 | 2026-07-23 | F-1 | 2026-08-17 | 0001213900-26-090325 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 14,212.41 | 2026-07-23 | F-1 | 2026-08-17 | 0001213900-26-090325 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 102.91M | 2026-07-23 | F-1 | 2026-08-17 | 0001213900-26-090325 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-07-07 | S-8 | 2026-07-07 | 0001193125-26-297458 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 5,383.82 | 2026-04-21 | F-1/A | 2026-04-21 | 0001193125-26-165337 |